Reacta Biotech

​Reacta Biotech develops, manufactures and commercialises oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP). The company was founded in June 2013 by its three founders: Professor Clare Mills, Professor Ashley Woodcock and Peter McPartland.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.